Welcome to our dedicated page for ORHUB news (Ticker: ORHB), a resource for investors and traders seeking the latest updates and insights on ORHUB stock.
ORHub, Inc. is a leading provider of surgical software that specializes in real-time surgical data analytics for the healthcare industry, hospitals, patients, government, and medical device vendors. Based in Phoenix, Arizona, the company offers cloud-based software solutions that capture surgical information before, during, and after surgery. Their software applications enable hospitals and medical device vendors to create anatomical graphic depictions during surgery using web-enabled devices.
Rhea-AI Summary
HippoFi's biotechnology business PUR Biologics announces Scott Bauccio as its new Head of Sales, leveraging his 20 years of sales management to expand sales and distribution channels, securing two new products: PURamnio and PURpeptide. The company aims to strengthen its leadership team and pursue innovation and excellence in the biologic sector, reflecting the first of several strategic actions in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.52%
Tags
-
Rhea-AI Summary
HippoFi's (ORHB) subsidiary, PUR Biologics, has made a significant breakthrough by entering the international market. With a strong distribution network and advanced technologies, the company is poised for substantial sales growth in 2024, targeting a $3.5 billion market for spine surgeries utilizing biological implants. The recent acquisition of activeOrb™ technology further positions the company for success in bone-growth solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.31%
Tags
-
Rhea-AI Summary
HippoFi's subsidiary, PUR Biologics (ORHB), is expanding its distribution network in California, aiming to provide innovative spine care solutions. With a focus on regenerating bone, cartilage, and spinal discs, PUR Biologics is positioned as a leader in spinal biologics, aiming to capitalize on the growing U.S. market for instrumented spine surgeries worth $3.5 billion annually. The company's expansion reflects its commitment to advancing healthcare technologies and solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
HippoFi, Inc. appoints Gail Naughton, a renowned expert in regenerative medicine, as Head of Regenerative Therapeutics and Commercialization. She brings a wealth of experience and a proven track record of success in the industry. Dr. Naughton's expertise will help HippoFi to develop and commercialize regenerative medicine solutions for unmet medical needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.15%
Tags
-
Rhea-AI Summary
HippoFi's subsidiary PUR Biologics expands sales globally through robust distribution channels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.81%
Tags
-
Rhea-AI Summary
PUR Biologics announces patent acquisition for groundbreaking device to enhance immune response and tap into lucrative medical markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
Rhea-AI Summary
HippoFi partners with Zimmer Biomet to introduce a synthetic biomaterial for bone growth under PUR Biologics, leading to FDA clearance and global license. Joint commercialization research agreement established. Positive impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.61%
Tags
-
Rhea-AI Summary
HippoFi to announce strategic partnership and asset acquisition with top 5 global leader in orthopedic industry
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
-
Rhea-AI Summary
ORHB - PUR Biologics Announces Patent for iPSC-ECM, Revolutionizing Cartilage Repair Market. With the global cartilage repair market projected to reach $3.5 billion by 2028, the demand for effective cartilage regeneration solutions has never been more pronounced. PUR Biologics is well positioned to capture a significant share of this lucrative market segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.67%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.62%
Tags
FAQ
What is the current stock price of ORHUB (ORHB)?
The current stock price of ORHUB (ORHB) is $0.014 as of July 23, 2024.
What is the market cap of ORHUB (ORHB)?
The market cap of ORHUB (ORHB) is approximately 23.1M.
Where is ORHub, Inc. based?
ORHub, Inc. is based in Phoenix, Arizona.
What does ORHub, Inc. specialize in?
ORHub, Inc. specializes in providing surgical software that focuses on real-time surgical data analytics for the healthcare industry.
What are the main products offered by ORHub, Inc.?
ORHub, Inc. offers cloud-based software solutions that capture surgical information before, during, and after surgery, allowing hospitals and medical device vendors to create anatomical depictions during surgery.
What is the recent achievement of ORHub, Inc.?
Recent news includes PUR Biologics' distribution channels expanding sales globally and the appointment of key personnel.
ORHUB INC